[Experimental validation of the use of alpha-adrenoblockers in combination with anticoagulants and fibrinolytic agents].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D002554:Cerebrosides / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005990:Glycerol / Q000627:therapeutic use; D007213:Indomethacin; D051381:Rats; D013927:Thrombosis / Q000097:blood / Q000188:drug therapy
D000317:Adrenergic alpha-Antagonists; D000925:Anticoagulants; D002554:Cerebrosides; D005343:Fibrinolytic Agents; D005990:Glycerol; D007213:Indomethacin
Eksperimental'noe obosnovanie ispol'zovaniia al'fa-adrenoblokatorov v sochetanii s antikoaguliantnymi i fibrinoliticheskimi sredstvami.